RCECS - Respiratory Care Educational Consulting Services, INC.

RCECS - Respiratory Care Educational Consulting Services, INC.RespiratoryNursingParamedic/EMT

RCECS Home
About Us
RCECS Accreditation
RCECS State CE Requirements
RCECS Course Offerings
RCECS Price Sheet
Frequently Asked Questions About RCECS
Testimonials About RCECS
Links
My Account At RCECS

PARAMEDIC / EMT COURSE OFFERINGS

We offer forty-nine copyrighted courses in six categories (series) of Respiratory Care

Assessment of Respiratory Disorders | Clinical Microbiology | General
Neonatal Respiratory Care | Synopsis of Respiratory Disorders | Therapeutic Procedures

49 courses are approved for California Paramedic/EMT instructor based CE credit.
(Note ALS or BLS after course descriptions for approved courses)
CA EMS CE Provider #33-0030

ASSESSMENT OF RESPIRATORY DISORDERS

HYPOXIA: CAUSES AND SYMPTOMS - Types of hypoxia (hypoxic, stagnant, anemic, histotoxic), clinical signs and symptoms of hypoxia. (2 CE contact hours) Revised 2005 ALS/BLS

back to top

CLINICAL MICROBIOLOGY

ANTHRAX: A BIOTERRORIST WEAPON - Characteristics, transmission, clinical manifestations, signs, symptoms and complications are described. (4 CE contact hours) Revised 2008 ALS/BLS

APPROACHES TO NOSOCOMIAL INFECTION PREVENTION AND CONTROL - Discussion of the means of pathogen transmission, the properties of well-known causes of nosocomial infections, risk factors and groups-at-risk for nosocomial infections, and recommended measures and practices (both general and specific) for the prevention and control of nosocomial infections. (7 CE contact hours) New 2007 ALS

AVIAN FLU - A POTENTIAL PANDEMIC? - General properties of all influenza viruses and the avian flu H5N1 strain are discussed. (4 CE contact hours) New 2006 ALS/BLS

BOTULISM AND TULAREMIA - TWO BACTERIAL BIOTERRORIST WEAPONS - Identifying the use of bacteria, bacterial toxins and viruses used by terrorists and knowing how to respond to the initial cases of these diseases are discussed . (3 CE contact hours) Revised 2008 ALS/BLS

HEPATITIS C - A MAJOR CONCERN FOR HEALTH CARE - Significant properties of HCV and associated infection, together with general features of hepatitis and viruses. (3 CE contact hours) New 2007 ALS/BLS

HIV INFECTION, HIV DISEASE AND AIDS (PAST, PRESENT AND FUTURE) - HIV transmission, clinical features, opportunistic infections, antiretroviral therapies, prevention and control strategies. (7 CE contact hours) Revised 2008 ALS/BLS

MENINGOCOCCAL DISEASE AND PNEUMOCOCCAL MENINGITIS - Features of bacterial meningitis and other related diseases, treatment, prevention and control. (3 CE contact hours) Revised 2006 ALS/BLS

MICROORGANISMS AND TERRORIST THREATS - This course primarily deals with the properties of those microorganisms and/or their products considered to be in the high-risk or most dangerous category. Attention is given to understanding the features of pathogens and the disease they cause together, and approaches to prevention and control. (6 CE contact hours) New 2006 ALS/BLS

MONKEYPOX AND RELATED POXVIRUS DISEASES - Monkeypox derives its' name from a series of outbreaks in nonhuman primate colonies in laboratories and a zoo that occurred between 1958 and 1968. The course presents the properties of several poxviruses and the disease they cause. (2 CE contact hours) New 2004 ALS

PERTUSSIS AND LEGIONELLOSIS - Outbreaks of Legionnaires' disease in hotels, cruise ships and office buildings, and an increase in Pertussis cases has renewed the concern within the health care industry regarding these two diseases. (3 CE contact hours) Revised 2008 ALS/BLS

PLAGUE AN ANCIENT SCOURGE AND POTENTIAL BIOWEAPON - History of plague, features of the Yersinia pestis and related bacterial disease agents. Means of transmission, clinical features, approaches to diagnosis, prevention and control. (2 CE contact hours) Revised 2005 ALS

PRION-CAUSED HUMAN DISEASES: WHAT HEALTH CARE PROVIDERS SHOULD KNOW - Types of prion-caused diseases, the nature of the prion, approaches to prevention and control. (2 CE contact hours) Revised 2006 ALS

SARS AND THE CORONAVIRUSES - Coronaviruses are well known as one of the most frequently encountered causes of the common cold. This course includes description of the properties and clinical features of coronavirus infection with an emphasis on the newly discovered SARS agent. (2 CE contact hours) Revised 2008 ALS/BLS

SEVERE CAUSES OF NOSOCOMIAL INFECTIONS - PSEUDOMONAS AERUGINOSA AND KLEBSIELLA PNEUMONIAE - The general properties of P. aeruginosa, K. pneumoniae, and related pathogenic species. Attention also is given to the organization of bacterial cell, virulence factors, approaches to prevention and control, and selected antibiotics and their mechanisms of action. (3 CE contact hours) New 2007 ALS

SMALLPOX REVISITED - History and features of smallpox and related viruses. Means of transmission, clinical features, approaches to diagnosis, vaccine and vaccine response reactions. (2 CE contact hours) Revised 2005 ALS/BLS

STAPHYLOCOCCUS AUREUS, ANTIBIOTIC RESISTANCE MECHANISMS, MRSA AND OTHERS - This course mainly presents the properties and features of diseases associated with one of the most common causes of hospital, and community-associated infections and diseases, namely S. aureus. (3 CE contact hours) New 2006 ALS

STREPTOCOCCAL PATHOGENS OF THE HUMAN RESPIRATORY SYSTEM - Characteristics of pathogenic streptococci and the range of respiratory and related illnesses they cause and the current approaches to the prevention and control of streptococcal diseases. (3 CE contact hours) New 2005 ALS/BLS

THE HEPATITIS VIRUS ALPHABET - Properties of the currently known hepatitis viruses, clinical features, vaccines and approaches to diagnosis. (7 CE contact hours) Revised 2004 ALS/BLS

THE HUMAN HERPESVIRUSES: MASTERS AT HIDING - General properties of human herpesviruses; Epidemiology, clinical features, transmission, diagnosis, treatment, prevention and recently uncovered herpesviruses. (4 CE contact hours) Revised 2006 ALS/BLS

THE HUMAN RESPIRATORY PARAMYXOVIRUSES - Discovery of human respiratory paramyxoviruses, general features and clinical manifestations of the viruses, and approaches to the prevention and control of illnesses caused by these paramyxoviruses. (2 CE contact hours) New 2005 ALS/BLS

VACCINES, THE HUMAN IMMUNE SYSTEM, AND IMMUNE RESPONSES - Concise descriptions of how the human immune system works, the bases of immune responses to pathogens and their products, and the range of vaccines that are currently available to combat a large number of infectious disease agents. (6 CE contact hours) New 2007 ALS

VIRAL HEMORRHAGIC FEVERS - Although anthrax and smallpox loom as the likeliest threats in a bioterrorism nightmare, the somewhat rare but deadly viral hemorrhagic fever agents pose a significant danger. This course presents several of the features of selected hemorrhagic fever viruses, the diseases they cause, and a brief discussion of the elements of bioterrorism. (3 CE contact hours) New 2004 ALS/BLS

WEST NILE VIRUS ENCEPHALITIS - A REEMERGING DISEASE - Details of West Nile Virus infection, clinical aspects, features of diagnosis, approaches to prevention and control. (1 CE contact hour ) Revised 2006 ALS/BLS

back to top

GENERAL

CONTINUOUS QUALITY IMPROVEMENT: METHODS AND TOOLS - Provides techniques to solve problems that interfere with quality patient care. (5 CE contact hours) Revised 2006 ALS/BLS

ETHICAL ISSUES FACING HEALTHCARE PROFESSIONALS - Social values, morals, principals and legal issues are discussed. (3 CE contact hours) Revised 2005 BLS

EVALUATION OF THE PULMONARY PATIENT - History, physical examination, lab data, radiology, interview, auscultation, bedside testing, textbook obstructive and restrictive disease patients. (3 CE contact hours) Revised 2003 ALS

NUCLEAR / BIOLOGICAL / CHEMICAL WARFARE: IMPLICATIONS FOR PRACTITIONERS - Types of threats, risks to practitioners, protection and decontamination methods are discussed. (5 CE contact hours) Revised 2008 ALS/BLS

PULMONARY ANATOMY AND PHYSIOLOGY - Airways, lung parenchyma, lung mechanics, volumes and capacities, defenses, alveolar expansion and stability, diffusion, O2 and CO2 transport, neurological control. (3 CE contact hours) Revised 2004 ALS/BLS

TICK-TRANSMITTED DISEASES: A GROWING PUBLIC HEALTH THREAT - Basic life cycles, methods of spreading pathogens, epidemiology, clinical features, diagnosis, treatment and prevention. (3 CE contact hours) New 2000 ALS/BLS

back to top

NEONATAL RESPIRATORY CARE

ACUTE PEDIATRIC RESPIRATORY ILLNESSES - Focuses on the diagnosis and treatment of the most common respiratory illnesses that cause the pediatric patient to be admitted to the acute care hospital. (3 CE contact hours) New 2004 ALS/BLS

NEONATAL RESPIRATORY CARE: CLINICAL APPLICATIONS - Indications, complications, devices/ modes, initiation, management and weaning of 02 therapy, aerosol therapy, CPAP, and mechanical ventilation, airway care, bronchial hygiene, assessment, monitoring. (9 CE contact hours) Revised 2007 ALS

NEONATAL RESPIRATORY CARE: ESSENTIAL CARE - Fetal lung development, circulation, hemoglobin, lung fluid, risk factors, assessment, surfactant, labor, delivery, equipment preparation for high-risk infants, heat loss, NTE, newborn assessment, neural control, work of breathing. (6 CE contact hours) Revised 2004 ALS

TENSION PNEUMOTHORAX IN THE PERINATAL/PEDIATRIC PATIENT - Recognition of signs and symptoms, causes and prevention, complications, treatment, management and monitoring of neonates at risk for or with the diagnosis of tension pneumothorax. (2 CE contact hours) Revised 2007 ALS/BLS

back to top

SYNOPSIS OF RESPIRATORY DISORDERS

ADULT RESPIRATORY DISTRESS SYNDROME - Pathophysiology and ARDS phases, etiology, clinical features, differential diagnosis, conventional and nonconventional treatment, complications, outcome. (5 CE contact hours) Revised 2008 ALS

ASTHMA - Types of asthma (extrinsic, intrinsic, occupational, exercise-induced, bronchial aspergillosis), pathology, causes, symptoms of acute attack, treatment, status asthmaticus, sedation, continuous nebulization, long-term management. (7 CE contact hours) Revised 2006 ALS

BACTERIAL PNEUMONIA - Pathology, predisposing factors, types of pneumonia (community-acquired, hospital-acquired, typical, atypical), diagnosis, causes, common bacterial pneumonias, treatment, complications. (5 CE contact hours) Revised 2007 ALS

CHEST TRAUMA - Blunt and penetrating chest trauma, diagnosis, symptoms, management and treatment, fractured ribs and sternum, flail chest, heart and lung trauma, hemothorax, empyema. (3 CE contact hours) Revised 2008 ALS

CHRONIC OBSTRUCTIVE PULMONARY DISEASE - Chronic bronchitis, emphysema, COPD, epidemiology, pathology, clinical history, diagnosis, symptoms, physical examination, ABG's, PFT's radiology, complications, treatment, prognosis. (5 CE contact hours) Revised 2008 ALS

CYSTIC FIBROSIS - DIAGNOSIS AND TREATMENT - How the Respiratory Therapist plays a significant role in the assessment and treatment of this complicated disease. (2 CE contact hours) Revised 2008 ALS/BLS

PNEUMOTHORAX - Lungs, pleura, types of pneumothorax (primary, secondary, iatrogenic, traumatic, tension), incidence, etiology, symptoms, diagnosis, management, treatment. (3 CE contact hours) Revised 2007 ALS

PULMONARY CONSEQUENCES OF HIV/AIDS - Pathogenesis of HIV, adult & pediatric pulmonary disease, diagnosis, treatment, intensive care, occupational risk & prevention, ethical issues. (2 CE contact hours) Revised 2008 ALS

PULMONARY EDEMA - Normal fluid leakage, factors affecting lung water, interstitium, driving pressures, barriers to leakage, causes, diagnosis, symptoms, treatment and prognosis. (3 CE contact hours) Revised 2007 ALS

PULMONARY TUBERCULOSIS - Epidemiology, transmission, clinical manifestations, diagnosis, treatment, chemotherapy, treatment regimens, prevention of TB. (2 CE contact hours) Revised 2005 ALS

TUBERCULOSIS AND OTHER BACTERIAL DISEASES - Features of tuberculosis and other mycobacterial species including the causes, transmission, pulmonary as well as extrapulmonary signs and symptoms, current approaches to diagnosis and treatment, multidrug-resistance and measures for prevention control. (4 CE contact hours) New 2005 ALS/BLS

back to top

THERAPEUTIC PROCEDURES

ARTIFICIAL AIRWAYS - Indications, complications, emergencies, care, intracuff monitoring, minimal leak technique, minimum occluding volume. (3 CE contact hours) Revised 2006 ALS

RESPIRATORY PHARMACOLOGY - Aerosol therapy, autonomic nervous system, mucociliary system, beta-adrenergic agonists, theophylline, anticholinergics, corticosteroids, cromolyn sodium, mucokinetics, mucolytics, antibiotics, virazole, pentamidine, respiratory stimulants, sedatives. (8 CE contact hours) Revised 2005 ALS

SUCTIONING THE AIRWAY - Indications, complications, equipment, continuous-use catheters, step-by-step procedure. (2 CE contact hours) Revised 2008 ALS/BLS

TRACHEOTOMY - Surgical procedure, types and sizing of tracheostomy tubes are discussed. (4 CE contact hours) Revised 2005 ALS/BLS

back to top


"Your Education Is Our Profession®"

RC EDUCATIONAL CONSULTING SERVICES, INC.
16781 Van Buren Blvd, Suite B, Riverside, CA 92504-5798
phone:  800-441-LUNG(5864) • 877-367-NURS(6877)
fax:  (951)789-8861
email:  info@rcecs.com

Designed & Maintained by PlainJoe Studios